Our study has uncovered a novel miR‐429‐CRKL‐Raf/MEK/ERK regulatory pathway in erythroid differentiation of CML and partially elucidated the molecular mechanism underlying erythroid differentiation in CML cells. This evidence concerns the gene CRKL and chronic myelogenous leukemia, BCR-ABL1 positive.